Mansur R, Ahmed J, Cha D, Woldeyohannes H, Subramaniapillai M, Lovshin J, et al
More research efforts are needed to develop guidelines regarding GLP-1 RA dose adjustments or discontinuations before such procedures and to improve both, procedural and patient-related, outcomes
THE PATIENT AND ANY OTHER PERSON RESPONSIBLE FOR PAYMENT HAS A RIGHT TO REFUSE TO PAY, CANCEL PAYMENT, OR BE REIMBURSED FOR PAYMENT FOR ANY OTHER SERVICE, EXAMINATION, OR TREATMENT THAT IS PERFORMED AS A RESULT OF AND WITHIN 72 HOURS OF RESPONDING TO THE ADVERTISEMENT FOR THE FREE, DISCOUNTED FEE, OR REDUCED FEE SERVICE, EXAMINATION, OR TREATMENT.
Why Body Mass Index Matters for GLP-1 Medications Doctors often bring up body mass index when prescribing GLP-1s
PMC 2265711